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Imprinted genes are expressed differently depending on whether
they are carried by a chromosome of maternal or paternal origin.
Correct imprinting is established by germline-specific modifi-
cations; failure of this process underlies several inherited human
syndromes1 – 5. All these imprinting control defects are cis-acting,
disrupting establishment or maintenance of allele-specific epi-
genetic modifications across one contiguous segment of the
genome. In contrast, we report here an inherited global imprint-
ing defect. This recessive maternal-effect mutation disrupts the
specification of imprints at multiple, non-contiguous loci, with
the result that genes normally carrying a maternal methylation
imprint assume a paternal epigenetic pattern on the maternal
allele. The resulting conception is phenotypically indistinguish-
able from an androgenetic complete hydatidiform mole6, in
which abnormal extra-embryonic tissue proliferates while
development of the embryo is absent or nearly so. This disorder
offers a genetic route to the identification of trans-acting oocyte
factors that mediate maternal imprint establishment.
Although normally sporadic, complete hydatidiform mole
(CHM) is occasionally familial, with affected women repeatedly
having pregnancies of this type. These repetitive CHMs are not
androgenetic but biparental (BiCHM)7 – 9. By analogy to disorders
like Prader–Willi syndrome (which can result from sporadic uni-
parental disomy or from familial imprinting control mutations), we
considered that BiCHM might arise from a global inherited failure
of maternal imprinting.
We studied the sixth molar pregnancy of the index case in a
BiCHM family with complex consanguinity, originating from the
Mirpur region of Pakistan. We demonstrated biparental origin of
the BiCHM DNA using markers on six autosomes.
Imprinted genes are associated with differentially methylated
regions (DMRs), either ‘primary’ (established during gametogen-
esis) or ‘secondary’ (established later in embryogenesis). We used
bisulphite sequencing10 to compare methylation in the BiCHM and
suitable controls, including uniparental DNAs and first-trimester
chorionic villus samples, which like CHMs, are of trophoblastic
origin.
The Beckwith–Wiedemann region of 11p15 contains two puta-
tive primary imprint control regions, at H19 and KCNQ1OT1,
,500 kilobases (500 kb) apart. The DMR ,2-kb upstream of H19
normally shows paternal-specific germline methylation11, and is
therefore an important control locus (Fig. 1a). Parthenogenetic (Pg)
and androgenetic (Ag) control DNAs were respectively completely
unmethylated and completely methylated at all CpG dinucleotides,
as expected. The BiCHM DNA shows a differentially methylated
pattern, like that of normal controls. Cloned polymerase chain
reaction (PCR) products from BiCHM were either almost com-
pletely methylated or completely unmethylated, as expected for
paternal or maternal alleles, respectively.) This maintenance of
normal H19 differential methylation in the BiCHM is as predicted,
if only imprinting in the female germ line is affected.
At loci with a maternal methylation imprint (Fig. 1b–e), a very
different pattern is seen. The KCNQ1OT1 primary DMR12,13
becomes methylated during oogenesis14. As expected, our normal
control DNAs are uniformly haplo-methylated (C and T bands of
similar intensity at each original CpG position), and the partheno-
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genetic sample fully methylated. In contrast, the BiCHM DNA is
completely unmethylated, its maternal KCNQ1OT1 allele thus
having a paternal epigenotype.
The 5 0 DMR of SNRPN (15q) behaved similarly. In the mouse,
this is a primary imprint15, but in humans may only become
established in early post-zygotic development16. In the BiCHM,
this DMR was completely unmethylated (paternal epigenotype),
whereas the parthenogenetic and Prader–Willi controls had the
opposite epigenotype (almost all CpGs completely methylated).
Chorionic villus samples and other normal controls were uniformly
haplo-methylated (Fig. 1c). AgCHM were hypomethylated com-
pared to normal DNA, but unlike the BiCHM did show faint bands
indicating some (presumably secondary) CpG methylation (see also
Supplementary Information).
PEG1 (7q32) and ZIM2/PEG3 (19q13.4)17,18 both have mater-
nally methylated DMRs. It is not known if these are primary
imprints, although the demethylated paternal PEG1 epigenotype
is established during spermatogenesis11. In the BiCHM, these
DMRs are both completely unmethylated (paternal epigenotype
on both alleles). At ZIM2/PEG3, the controls appear as predicted,
the normal DNAs being haplo-methylated, the PgDNA completely
methylated, and the AgCHM, like the BiCHM, unmethylated (Fig.
1e). However, at PEG1, whilst the normal and parthenogenetic
samples are respectively haplo-methylated and completely methyl-
ated (as expected) the AgCHM DNAs show a variable degree of
incomplete methylation (Fig. 1d).
To test whether the BiCHM methylation abnormalities truly
reflect a defect of maternal gametic imprinting, rather than being
secondary to the molar phenotype, we examined a complex locus,
GNAS1, that has multiple imprinted transcripts and at least three
separate DMRs19 – 22 (Fig. 2). In murine Gnas, the exon 1A DMR is a
primary imprint, whereas the upstream DMRs only become estab-
lished during the blastocyst stage22. Likewise, GNAS1 imprinting
mutations that cause type Ib pseudohypoparathyroidism (PHP-Ib)
always alter exon 1A methylation, with the other DMRs only
sometimes affected5. Therefore, a maternal germline imprinting
defect should involve failure to methylate the maternal allele of exon
1A. The maternal NESP55, XLas, and antisense promoter DMRs
(all 35–50 kb upstream) should then secondarily assume a paternal
epigenotype, becoming respectively methylated, unmethylated, and
unmethylated. This prediction was almost completely fulfilled. At
exon 1A, the parthenogenetic control, as expected, is completely
methylated, whereas the BiCHM is completely unmethylated,
indicating failure to establish the maternal primary imprint.
There is some variability in methylation in control samples; two
of ten chorionic villus sample DNAs are hypomethylated, and one of
three AgCHM appears partially methylated, suggesting that some
secondary methylation must have appeared at this locus. None-
theless, the unmethylated status of the BiCHM is as predicted, and
that this represents a true germline defect is supported by analysis of
the other DMRs at this locus.
The NESP55 DMR becomes methylated on the paternal allele
in the blastocyst stage, possibly secondary to antisense transcrip-
tion21,22. BiCHM and AgCHM are both completely methylated at
this DMR (paternal epigenotype on both alleles). All other controls
show the expected methylation patterns. Thus, the postzygotic
mechanism that sets up the secondary paternal NESP55 imprint
remains operative in the BiCHM, but in the absence of a maternal
gametic imprint at 1A this yields a paternal methylation pattern on
both, rather than one, NESP55 alleles.
We also examined two regions ,3 kb apart, within a large (5-kb)
CpG island spanning the antisense promoter and XLas exon. At the
antisense DMR, the BiCHM again shows a paternal epigenotype
(this time unmethylated) on both alleles. This lack of methylation is
distinctive, even though both AgCHMs show a minor degree of
secondary methylation at this locus.
The maternal XLas allele becomes methylated during the blas-
Figure 1 Bisulphite sequencing of DMRs in imprinted genes. Circles represent positions
and methylation of individual CpGs, as follows: filled, methylated; open, unmethylated;
half-filled black/white, haplo-methylated; black/grey, predominantly methylated; grey/
white, predominantly unmethylated. Identical results from multiple controls are collated,
numbers indicated to the right. a, H19. The first and last CpG are numbered relative to the
transcriptional start site. Arrows indicate differentially methylated C residues on the gel. N,
adult control DNA. Lanes: ACGT, left to right. b, KCNQ1OT1. Numbering refers to
accession AJ006345. c, SNRPN. Numbering relates to the first nucleotide of exon 1.
PWS, Prader–Willi syndrome. d, PEG1. e, ZIM2/PEG3. CVS, chorionic villus sample.
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tocyst stage22. Here we initially saw no sign of abnormal methyl-
ation in the BiCHM, the DNA appearing haplo-methylated. Similar
partial methylation at this DMR, independent of correct maternal
methylation at exon 1A, has been seen with cis-acting GNAS1
imprinting defects that cause PHP-Ib; several such families have
an abnormal (paternal) methylation pattern at exon 1A and
NESP55, whereas the XLas DMR appears unaffected5. Cloning of
the BiCHM bisulphite-PCR products, however, revealed a disor-
dered pattern of partial methylation scattered irregularly across the
clones, rather than the normal grouping into completely methylated
and completely unmethylated clones (see Supplementary Infor-
mation). A similar analysis has not been reported for the PHP-Ib
mutations. Thus, despite the appearance of some methylation at the
XLas DMR, the overall evidence from the four DMRs argues
compellingly for a GNAS1 imprinting defect in BiCHM, very similar
to that resulting from some maternally transmitted cis-acting
imprinting mutations.
The contrasting behaviour of H19 and GNAS1-NESP55 in the
BiCHM is noteworthy. Although both DMRs are normally pater-
nally methylated, for H19 this is primary, and therefore unaffected
by an oocyte defect. At NESP55, paternal methylation is secondary
to lack of a maternal imprint at 1A, and hence occurs on both alleles
in the BiCHM. This difference suggests that the BiCHM defect is not
a generalized failure of methylation maintenance, but reflects
specific events in the female germ line. Also consistent with this
conclusion was the observation of a normal methylated status in the
BiCHM at eight CpGs in an intragenic (non-CpG island) region of
the non-imprinted KHK gene (not shown). Other evidence argues
that the BiCHM methylation abnormalities reflect a specific
imprinting defect, rather than changes peculiar to trophoblast
derivatives. First, we see neither random nor generalized hypo- or
hyper-methylation; instead, at each DMR, the direction of the
BiCHM methylation abnormality is specifically as predicted for a
maternal germline defect. Second, despite some minor inter-sample
variation, chorionic villus sample DNAs (which, like the CHMs, are
first trimester trophoblast derivatives) typically had normal differ-
ential methylation, and never had a ‘paternal-only’ epigenotype
resembling that of the AgCHM and BiCHM.
Cis-acting mutations that disrupt imprinting at individual
loci1 – 5,12,13,23 – 24 show sex-dependent dominant (vertical) trans-
mission. In contrast, BiCHM is a pure maternal-effect defect;
affected women may have molar pregnancies with different part-
ners9, but are otherwise healthy. Its presumed autosomal recessive
inheritance pattern implies a trans-acting molecular defect, con-
sistent with the involvement of multiple dispersed imprinted loci.
Of all imprinted loci examined, only H19 (as predicted) showed a
normal differentially methylated pattern in the BiCHM. Because
most gametic imprints are imposed in the female rather than the
male germ line25, the great majority of all imprinted loci are
probably affected by this genetic defect. A recessive Dnmt3L
mutation, although also conferring male sterility, prevents specifi-
cation of maternal imprints in the mouse germ line26. In the family
studied here, lack of homozygosity for the corresponding human
locus, as well as for a previously suggested 19q BiCHM locus7(see
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Figure 2 Bisulphite analysis of GNAS1. At the top, the contrasting methylation status at
the 1A and NESP55 DMRs is illustrated; arrows on the gels indicate differentially
methylated residues. The remainder of the figure summarizes data for the whole locus (for
symbols see Fig. 1). In the schematic map of GNAS1, coding regions are black, antisense
exons grey. All alternative first exons on the sense strand splice onto exon 2 (refs 5, 21).
Arrows above and below the line indicate maternal and paternal transcription,
respectively. Normally methylated or unmethylated status of CpG islands is shown by filled
or open stars, respectively.
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Supplementary Information) makes involvement of either of these
loci unlikely. However, the BiCHM defect should eventually be
identifiable through autozygosity mapping. A
Methods
Detailed methods are available in Supplementary Information.
DNA samples
BiCHM DNA was extracted from a short-term culture of the evacuation products from the
sixth pregnancy of the index case. Four of her first five conceptions had previously been
histologically confirmed as CHM, and demonstrated to be biparental using archival
pathological material. Parthenogenetic DNA was previously described27. Adult control
blood DNAs were from the index case, her husband, and an unrelated individual.
Fluorescent PCR analysis of markers D1S2691, D5S495, D10S189, D13S1293, D17S946,
D19S210 and D19S413 was performed by standard methods on DNA from the cultured
BiCHM and from the index case and her husband; all these markers were fully informative
for demonstrating both maternal and paternal allelic contributions to the mole.
Bisulphite-PCR analysis of DNA methylation
The protocol was adapted from previously described methods10,24. Briefly, genomic DNA
was denatured and bisulphite-treated to convert unmethylated cytosines to thymines.
PCR products encompassing the DMRs of each imprinted locus were then generated. Only
one strand was amplified at each locus. Products were analysed by direct sequencing,
because at some loci the two modified alleles clone with different efficiencies. Cloning was
therefore used only to assess the allelic separation of C and Tat haplo-methylated loci (see
text).
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Recent studies have demonstrated that transplanted bone mar-
row cells can turn into unexpected lineages including myocytes,
hepatocytes, neurons and many others1. A potential problem,
however, is that reports discussing such ‘transdifferentiation’ in
vivo tend to conclude donor origin of transdifferentiated cells on
the basis of the existence of donor-specific genes such as Y-
chromosome markers1. Here we demonstrate that mouse bone
marrow cells can fuse spontaneously with embryonic stem cells
in culture in vitro that contains interleukin-3. Moreover, spon-
taneously fused bone marrow cells can subsequently adopt the
phenotype of the recipient cells, which, without detailed genetic
analysis, might be interpreted as ‘dedifferentiation’ or
transdifferentiation.
Recent progress in stem cell research indicates that certain
mammalian cells, even from adults, maintain a high degree of
plasticity for multilineage cell differentiation. The transferred nuclei
from adult cells could be reprogrammed by a factor or factors in the
cytoplasm of oocytes, showing the same potential for normal
animal development as early embryonic nuclei2. More recently,
neural stem cells were demonstrated to differentiate into virtually
every cell type when they were injected into blastocysts in vivo or
cultured in vitro with differentiating embryonic stem cells3. This
indicated that the extracellular factor(s) of blastocysts or embryonic
stem cells, or cell–cell interaction of neural stem cells with such
embryonic cells, might be sufficient for reprogramming adult cells
into a more pluripotent status. To this end, we attempted to
establish a culture of pluripotent stem cells in vitro from adult
cells (bone marrow cells) by nurturing them with embryonic stem
cells. Bone marrow contains haematopoietic stem cells producing
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Detailed methods
Supplementary information for Judson H. et al. “A global disorder 
of imprinting in the human female germline.”
Detailed methods
Methylation analysis of differentially methylated regions (DMRs) of imprinted genes
DNA (1 µg / 50 µl) was digested overnight with 25 units of PvuII (or BamHI in the case of 
SNRPN, where a PvuII site lies between the primers). Ethanol-precipitated products were 
resuspended in 50 µl TE buffer (pH 8.0). Following denaturation (with 5.5 µl 3M NaOH at 37°C 
for 15 minutes), 30 µl 10 mM hydroquinone, and 520 µl (3.6M) sodium bisulphite pH 5.0 were 
added. The reactions were incubated at 55°C for 16 hours. DNA was purified with GenecleanTM 
(Bio101), and eluted into 20 µl water. A further denaturation was performed by adding 2.2 µl 3M 
NaOH and incubating at 37°C for 15 minutes. The denatured modified DNA was ethanol-
precipitated and resuspended in 15 µl TE; 2 µl was used per 50 µl PCR reaction. PCR primer 
sequences and cycling conditions were as follows:
H19: dTGTATAGTATATGGGTATTTTTGGAGGTTT and 
dTCCTATAAATATCCTATTCCCAAATAACC (Kerjean et al., ref. 11 in main text). 35 cycles 
of 94, 52, 72ºC; 45, 45, 90 s. Sequencing primer dTTTTGGTTTTATTGTTTGGATGGTA. The 
region sequenced was nt 6115-6326 of AF087017.
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KCNQ1OT1 (LIT1): dTGTTGAGGAGTTTYGGGGAGGATTA and 
dCACCTCACACCCAACCAATACCTCAT (40 cycles of 94, 50, 72ºC; 45, 45, 60 s). Sequenced 
with dTTGGTAGGATTTTGTTGAGGAGTTTT or dAAACCAAACTCTTTCAACCAATAAC. 
SNRPN: Nested PCR1. First round: dGGTTTTTTTTTATTGTAATAGTGTTGTGGGG and 
dCTCCAAAACAAAAAACTTTAAAACCCAAATTC. Second round: 
dCAATACTCCAAATCCTAAAAACTTAAAATATC and 
dGGTTTTAGGGGTTTAGTAGTTTTTTTTTTTTTGG (also used as a sequencing primer). 35 
cycles of 94, 51, 72ºC; 60, 60, 60 s. 2.5 µl were then diluted into a fresh 50 µl reaction and 
reamplified for a further 25 cycles.
PEG1: dtygttgttggttagttttgtayggtt and dAAAAATAACACCCCCTCCTCAAAT (Kerjean et al., 
ref. 11 in main text). 40 cycles of 94, 61, 72ºC; 45, 45, 60s. Sequencing primer 
dAAAATTTCRACCCAAAAACAACCCC.
ZIM2/PEG3: dAAAAGGTATTAATTATTTATAGTTTGGT and 
dAAAAATATCCACCCTAAACTAATAA (also used as a sequencing primer). 6 cycles of 94ºC 
30s, -1ºC/s ramp to 60ºC, 60ºC 20s (-1ºC/cycle), 72ºC 60s; 6 cycles of 94ºC 30s, -1ºC/s ramp to 
55ºC, 55ºC 20s (-1ºC/cycle), 72ºC 60s; 32 cycles of 94ºC 30s, 1ºC/s ramp to 50ºC, 50ºC 20s, 72ºC 
60s.
GNAS1. The positions of each amplicon were: exon 1A, nt 29821-30039 of AL121917; NESP55, 
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106677-107019 of AL132655; XLαs, 120557-120954 of AL132655; antisense promoter, 117154-
117607 of AL132655.
GNAS1-1A: Nested PCR. First round (35 cycles of 94, 55, 72ºC; 45, 45, 90 s): 
dTTTTGTTTTTTTTTYGTTTGTTTAT and dACAACTTCRACAACCACCTCRACAAC. 
Second round (25 cycles using 2 µl of first round products): 
dTAAACTTCATAACCATCTTCAACATAA and 
dTTAATTTTTAGGTAGTTAGTTTAGTAGTT (also used as a sequencing primer).
GNAS1-NESP55: dTTTTTGTAGAGTTAGAGGGTAGGT (also used as a sequencing primer), 
and dAAATAAAACAACTCAAAATCTACC (40 cycles of 94, 50, 72ºC; 45, 45, 60 s).
GNAS1-antisense: dTATTTGTGTAGGTTTAGTATTTTTGG and 
dCATCCTCTAAATAACCCAACTAAATC (40 cycles of 94, 54, 72ºC; 45, 45, 60 s). Sequencing 
primer: dAAACAAAAATCATACCAATCAAAAC.
GNAS1-XLαs: dGTTGGTTTTAGAGGAGGTTATAGTT and 
dCCTCCTCAACTAAAAATCTCTCTAC (40 cycles of 94, 54, 72ºC; 45, 45, 60 s). Sequencing 
primer: dGTTATTTGAGTTTGATGGAGAAGG.
KHK: dTTTAGTAGTTTTGTTTTGGATGATT and dACAACTAACAAAACACAAACAATTA 
(8 cycles of 94ºC 30s, 0.5ºC/s ramp to 59ºC, 59ºC [-1ºC/cycle] 30s, 72ºC 60s; 32 cycles of 94ºC 
30s, 0.5ºC/s ramp to 50ºC, 50ºC 30s, 72ºC 60s).
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PCR products were treated with shrimp alkaline phosphatase and exonuclease I, and cycle-
sequenced with a Thermosequenase 33P-labelled terminator kit (AmershamPharmacia). dITP was 
needed to reduce the effect of GC compressions, which otherwise cause differential migration of 
the allelic sequences on the sequencing gel. Cycling conditions were 50 cycles of 95ºC for 30 s, 
50ºC for 30 s, and 60ºC for 7 minutes.
 
 
Figure 1. Pedigree of BiCHM family. 
Filled diamonds indicate molar pregnancies. The index case IV:4 is arrowed. Known 
consanguineous matings are indicated by double bars. Filled circles indicate affected women 
(presumed homozygous by descent for the causative mutation), who are, however, themselves 
phenotypically normal except during pregnancy. DNA from affected individuals IV:4 and III:14 
was used for genetic analysis.
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Marker Map position (Mb)
www.ensembl.org
III:14 IV:4
    
D19S418 67.5 84/84 84/86
D19S926 67.58 176/178 176/180
D19S605 67.9 113/117 115/117
CA025588 70.6  181/193
D19S887 70.7 245/253 253/253
GT011499 = D19S40470.7  100/110
D19S573 70.3 225/225 225/229
D19S210 70.1 165/175 165/175
D19S214 70.9 164/170 170/178
D19S218 71.3 203/217 203/217
    
DNMT3L 42.4   
D21S1411 41.0 287/291 287/291
D21S1912 42.4 213/239 213/239
D21S1446 44.8 208/208 208/224
 
Table 1. Genetic analysis of candidate BiCHM loci. 
Homozygous markers are shaded in grey. Autozygosity mapping was previously used in two 
consanguineous families to suggest a BiCHM locus on 19q13.3-q13.4 (Moglabey et al. 1999, ref. 
7 in main text). The genetic map in this candidate region was reported as: D19S418-2.1-(D19S926/
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D19S605)-5.2-D19S887-0.1-(D19S573/D19S210)-1.2-D19S214-1.3-D19S218 (with distances in 
centiMorgans). None of the markers within this previously suggested linkage interval is 
homozygous in both affected women available in the present family. Because of the 5 cM gap 
between D19S605 and D19S887, respectively heterozygous and homozygous in IV:4, we 
additionally identified and typed two markers that flank D19S887 by <100 kb on each side. Both 
these markers (CA025588 and GT011499, identical to D19S404) being heterozygous in IV:4, 
homozygosity by descent for D19S887 was ruled out. Recessive mutation of the mouse Dnmt3L 
gene prevents maternal imprint establishment and causes male sterility. This gene does not appear 
to be involved in our BiCHM family since there is no homozygosity by descent for markers 
closely surrounding it (marker order D21S1411-DNMT3L-D21S1912).
Figure 2. Clonal analysis of bisulphite-PCR products from BiCHM. 
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Methylation analysis was mostly performed as described above by direct sequencing of bisulphite-
PCR products, since this avoids problems of cloning bias at some loci. However, some loci 
displaying a mixed methylation pattern on direct sequencing were analysed by cloning to assess 
the allele-specificity of this methylation. One clone per horizontal line; black symbol = 
methylated residue; white symbol, unmethylated residue. a, H19. Labelling of CpGs is as in 
Kerjean et al., ref. 11 in main text. The distribution of methylated and unmethylated CpGs is 
indistinguishable from that in normal somatic tissues. It is consistent with unimpaired 
establishment and maintenance of a paternal imprint at H19 in the BiCHM. b, GNAS1-XLαs. This, 
as discussed in the main text, was the only maternally methylated DMR not to show clear 
evidence of a defect in the BiCHM on direct sequencing. This retention of differential methylation 
has also been noted in some PHP-Ib patients with cis-acting imprinting mutations at this locus. 
However, the cloned BiCHM GNAS1-XL products show a strikingly different appearance from 
that of H19. This suggests that the appearance on direct sequencing does not reflect normal 
imprinting at GNAS1-XL, but a rather disordered scattering of methylated residues across both 
alleles.
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Figure 3. Clonal analysis of bisulphite-PCR products from AgCHM. 
At several loci, the BiCHM methylation pattern is indistinguishable from that of AgCHM (H19 
representing an important predicted exception). However, at four DMRs (PEG1, KCNQ1OT1, 
SNRPN and GNAS1-1A), the BiCHM epigenotype actually appears even more purely “paternal” 
than that of the AgCHM. The reason for this is unclear, though it implies that the presence of an 
extra paternal allele (rather than an abnormal maternal one) increases the susceptibility of the 
CHM to acquiring abnormal postzygotic methylation changes. The failure of AgCHM to conform 
perfectly to the expected paternal methylation pattern has been reported previously2. There is also 
evidence that early uniparental mouse embryos may “adjust” methylation patterns towards those 
of normal biparental embryos, perhaps implying the existence of a dosage compensation 
http://0-www.nature.com.wam.leeds.ac.uk/nature/journal/v416/n6880/extref/416539a-s1.htm (8 of 10)26/08/2004 13:23:46
Detailed methods
mechanism similar to that of X-inactivation3. Possibly, therefore, such a process could influence 
the methylation patterns eventually observed in the androgenetic moles. Two examples of clonal 
analysis of AgCHM are shown.a, SNRPN. Figure 1c in the main text shows that both AgCHM 
displayed a minor degree of SNRPN DMR methylation (normally only seen on a maternal allele). 
The clones show a striking contrast to the strictly haplomethylated pattern we show above for H19 
in the BiCHM. Our interpretation is that a degree of secondary methylation is occurring in 
AgCHM, but that it is incomplete and quite probably not allele-specific. The overall proportion of 
methylated C residues (14%) agrees with visual assessment of the directly sequenced PCR 
product. b, GNAS1-1A. Figure 2 in the main text indicates that one of the AgCHM showed 
approximately equal intensity of methylated and unmethylated signals at all the CpG positions. 
GNAS1-1A clones from this AgCHM are either almost completely methylated or unmethylated. It 
is unclear whether or not this reflects allele-specificity, since we cannot distinguish the two 
paternal alleles at this locus. It remains possible that the pattern results not from allele-specificity, 
but from cooperative kinetics of de novo methylation. 
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